
Cofepris approves therapy against metastatic breast cancer
Metastatic breast cancer is one of the deadliest there is because 77.7% of women who suffer from it die in five years or less. The novel therapy reduced the risk of death by 36% and decreased the risk of disease progression by 64%. Experts say that the …